Biol stock forecast.

Find real-time BIO - Bio Rad Laboratories Inc stock quotes, company profile, news and forecasts from CNN Business. Forecast for July 2025. It is predicted that the price of one BIOLASE share in will be in the range of $0.95 to $1.11. The width of this range will be $0.17 (15.15%). The average price is $1.05, which is $0.07 higher than the average price of the previous month.Get The Latest MRNA Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ... 294th out of 957 stocks. Biological Products, Except Diagnostic Industry. 46th out of 158 stocks. 4.1 Analyst's Opinion. ... View our MRNA earnings forecast.Find real-time BIO - Bio Rad Laboratories Inc stock quotes, company profile, news and forecasts from CNN Business.BIOLASE Stock Forecast 10 Nov. Presumably, on 11/10/2023, the price of shares will be in the range of $1.63 - $1.68. A $0.04 range width can provide 2.55% volatility. The weighted average price of this range is at $1.65, which is $0.02 lower than the previous day's weighted average price.

According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. Learn more on BIOL's analyst rating history.

About the BIOLASE, Inc. stock forecast. As of 2023 November 18, Saturday current price of BIOL stock is 1.255$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Biolase stock price has been showing a declining tendency so we believe that similar market segments were not very …Nov 29, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The average twelve-month price prediction for BIOLASE is $77.00 with a high price target of $150.00 and a low price target of $4.00. Learn more on BIOL's analyst rating history.

Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Based on short-term price targets offered by three analysts, the average price target for Biolase comes to $15.67. The forecasts range from a low of $3.00 to a …Amgen ( AMGN, $252.17), founded in 1980, is a pioneer in biologics. Total product sales accounted for 93.5% of AMGN's 2021 revenues. The company's three top-selling drugs are Enbrel for ...BIOL Stock Predictions, Articles, and Biolase Inc News From InvestorPlace From the Web Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday By William White ...

Based on 6 Wall Street analysts offering 12 month price targets for Genmab in the last 3 months. The average price target is $45.20 with a high forecast of $54.00 and a low forecast of $32.00. The average price target represents a 43.26% change from the last price of $31.55. Highest Price Target $54.00. Average Price Target $45.20.

BIOL Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. BIOLASE, INC. Compare. BIOLASE, INC. 0.27 ...

It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Workhorse Group share forecasts, stock quote and buy / sell signals below. According to present data Workhorse Group's WKHS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic ...Real time Biolase (BIOL) stock price quote, stock graph, news & analysis. There was a snowstorm in the Northeast this week. Or maybe that supposed storm was just a light dusting. It depends on who you ask. Having grown up in the mountains of Colorado, I am well aware at just how terrible these forecasts tend to b...Ticker: BIOL. Sector: Healthcare. Closing price of the last trading day: $1.66. Last trading day: 10/25/2023. Analyst forecast price: $20.5. 52-week high/low: $23.48 / $3.3. Shares of BIOLASE, Inc. are traded on the stock exchange under the ticker BIOL, marking their space in the competitive " Healthcare " sector.

How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997. Find the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook ...The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors The Biolase Inc ( BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1639.46% increase from …The Clean Vision Corporation stock price fell by -6.75% on the last day (Friday, 1st Dec 2023) from $0.0467 to $0.0436. During the last trading day the stock fluctuated 15.38% from a day low at $0.0416 to a day high of $0.0480. The price has fallen in 6 of the last 10 days and is down by -7.34% for this period.

Find the latest Unity Biotechnology, Inc. (UBX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...0.06%. $36.28B. bioMerieux S.A. -0.33%. €11.49B. BIO | Complete Bio-Rad Laboratories Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Financials. Next reporting date. February 1, 2024. EPS forecast (this quarter) $0.45. Annual revenue (last year) $1.1B. Annual profit (last year)The bad news for investors in BIOL stock is the company’s earnings per share of -18 cents for the period. That’s worse than Wall Street’s estimate of -10 cents for the quarter. However, it ...Find the latest Salarius Pharmaceuticals, Inc. (SLRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...The chart below shows the historical price of BIOLASE stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BIOLASE stock price can be found in the table below.Find the latest Twist Bioscience Corporation (TWST) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.Nov 13, 2023 · High Growth Earnings: BIOL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: BIOL's revenue (10% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: BIOL's revenue (10% per year) is forecast to grow slower than 20% per year. Nov 24, 2021 · BIOL stock has been on a steady decline for several years now. A publicly traded company since 1992, its stock had been trading at just under $100 per share in 2004. However, since that peak, the ... Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Find the latest ImmunityBio, Inc. (IBRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

Cathie Wood. Brendan McDermid/Reuters. Ark Invest CEO Cathie Wood expects synthetic-biology companies to take off in the next five years. "There is going to be explosive growth that most people in ...

BIOL Forecast — Price Target — Prediction for 2024 BIOL 1.24 +0.02 +1.64% Markets / USA / Stocks / Health Technology / Medical Specialties / BIOL / Forecast Biolase, Inc. …In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.The chart below shows the historical price of BIOLASE stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BIOLASE stock price can be found in the table below.The Biolase Inc ( BIOL) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $21.75, representing a +1639.46% increase from …Find the latest Gossamer Bio, Inc. (GOSS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 13, 2023 · Their BIOL share price forecasts range from $5.00 to $14.00. On average, they anticipate the company's share price to reach $9.50 in the next year. This suggests a possible upside of 2,251.5% fromFind real-time BIO - Bio Rad Laboratories Inc stock quotes, company profile, news and forecasts from CNN Business.Artificial Intelligence Technology Solutions saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 75,400 shares, an increase of 2,692.6% from the October 15th total of 2,700 shares. Based on an average trading volume of 72,060,200 shares, the short-interest ratio is currently 0.0 days.Jul 26, 2023 · COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's stockholders granted the Board of Directors the discretion to effect a ... 1 equities research analysts have issued 1 year price targets for Cassava Sciences' shares. Their SAVA share price targets range from $11.00 to $124.00. On average, they predict the company's share price to reach $54.33 in the next year. This suggests a possible upside of 154.5% from the stock's current price.

Find the latest Sonnet BioTherapeutics Holdings, Inc. (SONN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook ...Financials. Next reporting date. February 1, 2024. EPS forecast (this quarter) $0.45. Annual revenue (last year) $1.1B. Annual profit (last year)BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 13, 2023 · About BIOLASE (NASDAQ:BIOL) Stock BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.Instagram:https://instagram. how to pick crypto for day tradingshare rate of nestlescan stocksbest way to option trade Based on 3 Wall Street analysts offering 12 month price targets for American Superconductor in the last 3 months. The average price target is $15.67 with a high forecast of $23.00 and a low forecast of $10.00. The average price target represents a 102.19% change from the last price of $7.75. Highest Price Target $23.00. arlp stock dividendbest desktop for stock trading BIOL's price to book (P/B) is 81% more than its last 4 quarters average of 2.0 but 38% less than its 5-year quarterly average of 5.8 The stock's price to sales (P/S) is 97% less than its 5-year quarterly average of 1.0 and 70% less than its last 4 quarters average of 0.1Find the latest Bio-Rad Laboratories, Inc. (BIO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ... outdoorzy BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 17, 2023 · BIOLASE (NASDAQ:BIOL) has a market capitalization of $3.32 million and generates $39.19 million in revenue each year. The medical technology company earns $-16,160,000.00 in net income (profit) each year or ($3.57) on an earnings per share basis.Based on short-term price targets offered by three analysts, the average price target for Biolase comes to $15.67. The forecasts range from a low of $3.00 to a …